Effect of Recombinant Human Growth Hormone Treatment in a Patient with Short Stature Associated with the Ring Chromosome 17 Syndrome

• Váldodahkkit: Gustavo Tempone Cardoso Penna (Dahkki), Gabriela de Rezende Lelot (Dahkki), Ana Luiza de Rezende Lelot (Dahkki), Juliana Greghi Hernandez (Dahkki), Carolina Costa Figueiredo (Dahkki), Nara Michelle de Araujo Evangelista (Dahkki), Vania de Fatima Tonetto Fernandes (Dahkki), Guido de Paula Colares Neto (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2023-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background. Ring chromosome 17 syndrome is a rare hereditary disorder whose prevalence is less than 1 : 1.000.000. We present a ten-year-old patient with ring chromosome 17 syndrome who had short stature and was treated with recombinant human growth hormone (rhGH). Case Report. A ten-year-old male s...